UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041229
Receipt number R000046839
Scientific Title Rapid objective audiometry using EEG
Date of disclosure of the study information 2020/07/28
Last modified on 2022/04/18 12:31:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Rapid objective audiometry using EEG

Acronym

Rapid objective audiometry using EEG

Scientific Title

Rapid objective audiometry using EEG

Scientific Title:Acronym

Rapid objective audiometry using EEG

Region

Japan


Condition

Condition

Hearing loss

Classification by specialty

Oto-rhino-laryngology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective is to validate rapid objective audiometry using EEG.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation with pure-tone audiometry

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

EEG measurement(once)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Hearing loss patient: slight to mild hearing loss(> 70 dB) patients subject to pure-tone audiometry who are 20 years old or older.
Normal hearing subject: normal hearing(> 25 dB) subjects who are 20 years old or older.

Key exclusion criteria

Hearing loss patient: patients with central nervous system diseases, patients after brain surgery, and patients who do not wish.
Normal hearing subject: subjects who do not wish.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Sho
Middle name
Last name Kanzaki

Organization

Keio University

Division name

Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine

Zip code

160-8582

Address

Shinanomachi 35, Shinjuku-ku, Tokyo

TEL

03-5363-3827

Email

skan@keio.jp


Public contact

Name of contact person

1st name Sho
Middle name
Last name Kanzaki

Organization

Keio University

Division name

Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine

Zip code

160-8582

Address

Shinanomachi 35, Shinjuku-ku, Tokyo

TEL

03-5363-3827

Homepage URL


Email

skan@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

The University of Tokyo

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

The University of Tokyo

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University

Address

Shinanomachi 35, Shinjuku-ku, Tokyo

Tel

03-3353-1211

Email

skan@keio.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2019-0274

Org. issuing International ID_1

Keio University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 03 Day

Date of IRB

2020 Year 06 Month 22 Day

Anticipated trial start date

2020 Year 08 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 07 Month 28 Day

Last modified on

2022 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046839


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name